ERBB2 and breast cancer: Here, we report that targeting cells with biotinylated ligands and subsequent addition of SA efficiently targets Tf, W6/32, and TRz to lysosomes and also enhances the degradation of Her2 in breast cancer cell lines that overexpress this receptor.